ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Down – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price gapped down before the market opened on Thursday. The stock had previously closed at $14.88, but opened at $13.60. ChronoScale Corporation Common Stock shares last traded at $13.20, with a volume of 61,246 shares.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CHRN shares. Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, October 9th. Northland Securities started coverage on shares of ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target for the company. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $19.00.

ChronoScale Corporation Common Stock Trading Up 0.8%

The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06. The company has a market cap of $2.18 billion, a PE ratio of -2.79 and a beta of 0.98. The company has a fifty day simple moving average of $19.98 and a two-hundred day simple moving average of $18.15.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The company had revenue of $41.48 million during the quarter.

Institutional Trading of ChronoScale Corporation Common Stock

A hedge fund recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc boosted its position in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,338 shares of the company’s stock after acquiring an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent quarter. Institutional investors and hedge funds own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.